ECP
ARLZ

Elk Creek Partners’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Elk Creek Partners’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,488,475
Closed -$5.33M – 166
2017
Q1 		$5.33M Buy
2,488,475
+292,420
+13% +$1.1M 0.33% 103
2016
Q4 		$9.69M Buy
2,196,055
+55,004
+3% +$261K 0.65% 61
2016
Q3 		$10.4M Buy
2,141,051
+626,133
+41% +$2.86M 0.68% 59
2016
Q2 		$5M Buy
1,514,918
+122,172
+9% +$461K 0.36% 100
2016
Q1 		$4.94M Buy
+1,392,746
New +$7.18M 0.37% 98

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.44B AUM 28.5% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return